RHÖN-KLINIKUM Aktiengesellschaft AI Price Prediction

With EPS at €0.57 and a PE ratio of 22.28, RHÖN-KLINIKUM is priced at a moderate premium relative to its earnings, suggesting the market expects stable but not explosive growth. Without full revenue and margin history, the valuation implies decent profitability but not deep-value territory. Overall, the earnings profile looks steady rather than strongly cyclical or high growth.

• EPS of €0.57 combined with a share price of €12.70 yields a PE of 22.28, indicating investors are willing to pay a moderate premium for each euro of earnings.
• A mid‑20s PE in a defensive sector like healthcare/hospitals typically reflects expectations of stable cash flows rather than high growth, pointing to a fairly valued to slightly expensive stock.
• No evidence of extreme undervaluation or overvaluation from the limited metrics provided; profitability appears adequate but not exceptional, supporting a neutral stance.

The stock is trading at €12.70, modestly above its 200‑day moving average of €12.53, with a 4.1% gain over the last month. An RSI of 60.69 indicates positive momentum but not overbought conditions. Overall, technicals point to a mild uptrend without strong signals of either a breakout or imminent reversal.

• Price at €12.70 vs. a 200‑day moving average of €12.53 suggests the stock is slightly above its long‑term trend, consistent with a gentle upward bias rather than a strong rally.
• A 4.1% increase in the last month indicates improving sentiment and short‑term momentum, but the move is moderate, not parabolic.
• RSI at 60.69 is in bullish territory but below the typical overbought threshold of 70, implying room for further upside while also signaling that the easy gains may already be partly realized.

Website traffic and app downloads are flat month over month, suggesting stable digital engagement rather than accelerating demand. Job openings have risen 5.5% MoM, which can indicate cautious expansion or investment in capacity. Social media followings are growing modestly on most platforms, pointing to steady but unspectacular brand engagement.

• Web traffic at ~10,378 visitors per month and app downloads at ~1,000 per day are both flat MoM (0.0% change), signaling neither deterioration nor strong new demand momentum from digital channels.
• Job openings at 153, up 5.5% MoM, may reflect hiring to support operations or growth initiatives, a mildly positive operational signal if not driven solely by turnover.
• Social media metrics show small but broad‑based growth on Instagram (+2.2%), Facebook (+1.6%), YouTube (+1.2%), and a stable LinkedIn base, offset by a slight decline on Twitter/X (‑0.2%), overall indicating steady, incremental brand engagement rather than a major shift in public interest.

Taken together, RHÖN-KLINIKUM Aktiengesellschaft’s valuation, technical picture, and alternative data suggest a stable, defensive profile with modest positive momentum but no strong catalyst. The stock trades at a reasonable earnings multiple, sits slightly above its long‑term trend, and shows steady—though not accelerating—operational and engagement signals. Overall, the evidence points to a neutral outlook with a slight positive bias rather than a clearly bullish or bearish setup.

• Fundamentals and valuation (PE ~22) indicate a fairly valued defensive healthcare name, with expectations for stable earnings rather than high growth.
• Technicals and alternative data show mild positive momentum and operational stability, but lack strong inflection points that would justify a distinctly bullish or bearish view.